Palermos J - Search Results

1

Effect of pamidronate administration on markers of bone turnover and disease activity in multiple myeloma.

Terpos E, Palermos J, Tsionos K, Anargyrou K, Viniou N, Papassavas P, Meletis J, Yataganas X. Terpos E, et al. Among authors: palermos j. Eur J Haematol. 2000 Nov;65(5):331-6. doi: 10.1034/j.1600-0609.2000.065005331.x. Eur J Haematol. 2000. PMID: 11092464 Clinical Trial.

2

Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin-6 and beta 2-microglobulin in multiple myeloma.

Terpos E, Viniou N, de la Fuente J, Meletis J, Voskaridou E, Karkantaris C, Vaiopoulos G, Palermos J, Yataganas X, Goldman JM, Rahemtulla A. Terpos E, et al. Among authors: palermos j. Eur J Haematol. 2003 Jan;70(1):34-42. doi: 10.1034/j.1600-0609.2003.02823.x. Eur J Haematol. 2003. PMID: 12631257 Clinical Trial.

3

Pamidronate increases markers of bone formation in patients with multiple myeloma in plateau phase under interferon-alpha treatment.

Terpos E, Palermos J, Viniou N, Vaiopoulos G, Meletis J, Yataganas X. Terpos E, et al. Among authors: palermos j. Calcif Tissue Int. 2001 May;68(5):285-90. doi: 10.1007/BF02390835. Calcif Tissue Int. 2001. PMID: 11683535 Clinical Trial.

4

Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia.

Voskaridou E, Terpos E, Spina G, Palermos J, Rahemtulla A, Loutradi A, Loukopoulos D. Voskaridou E, et al. Among authors: palermos j. Br J Haematol. 2003 Nov;123(4):730-7. doi: 10.1046/j.1365-2141.2003.04657.x. Br J Haematol. 2003. PMID: 14616979 Free article.

5

Changing patterns of bacterial nosocomial infections: a nine-year study in a general hospital.

Maniatis AN, Trougakos IP, Katsanis G, Palermos J, Maniatis NA, Legakis NJ. Maniatis AN, et al. Among authors: palermos j. Chemotherapy. 1997 Jan-Feb;43(1):69-76. doi: 10.1159/000239538. Chemotherapy. 1997. PMID: 8996745

6

Streptococcus agalactiae: a vaginal pathogen?

Maniatis AN, Palermos J, Kantzanou M, Maniatis NA, Christodoulou C, Legakis NJ. Maniatis AN, et al. Among authors: palermos j. J Med Microbiol. 1996 Mar;44(3):199-202. doi: 10.1099/00222615-44-3-199. J Med Microbiol. 1996. PMID: 8636937

7

Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency.

Volanakis JE, Zhu ZB, Schaffer FM, Macon KJ, Palermos J, Barger BO, Go R, Campbell RD, Schroeder HW Jr, Cooper MD. Volanakis JE, et al. Among authors: palermos j. J Clin Invest. 1992 Jun;89(6):1914-22. doi: 10.1172/JCI115797. J Clin Invest. 1992. PMID: 1351062 Free PMC article.

8

Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes.

Schaffer FM, Palermos J, Zhu ZB, Barger BO, Cooper MD, Volanakis JE. Schaffer FM, et al. Among authors: palermos j. Proc Natl Acad Sci U S A. 1989 Oct;86(20):8015-9. doi: 10.1073/pnas.86.20.8015. Proc Natl Acad Sci U S A. 1989. PMID: 2573059 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters